Impono LLC
Strengthening Science Companies and Science Education for Global Public Good

Example 1: Simultaneous Start-Up Launch & Product Launch (Venture Capital)

​

Remit: Accelerate the launch of a start-up business while also accelerating the launch of a first product 

​

The Context:

Start-up received priority review for new diagnostic agent, accelerating launch by 2ce the original plan.  The business required an expedited start-up process to promote agility and efficiency, an adjusted forecast within weeks of drug approval, an accelerated management/sales/medical affairs staffing plan, and a revised strategy-check calendar to assure the accelerated launch performed optimally given its launch during an industry-recognized "slow season."  The assignment also required someone with multi-functional experience to step into various management team roles on a short-term basis while the start-up staffed-up.

​

This company in Case #1 is backed by a publicly traded venture capital organization; although no client names are disclosed in these cases, the details listed below are written so as to preserve appropriate disclosures.  This case will be updated accordingly when more details are made public. 

​

The Impono Design, Post In-Take:

• Evaluate existing strategy; create an integrated execution plan for efficient use of small start-up team

• Clarify execution tactics to assure critical focus; parallel tactics with additional business needs

• Assume various interim management team roles during 1st year as team assembles

• Implement and scale critical business operations during accelerated growth

• Hire or assist the hire of at least 50% of management team through network of highly-regarded talent 

​

Impono's Primary Activities & Results:

• Accelerated business and product launches by re-designing the existing silo’d launch plan into an integrated model with efficient, parallel activities while assisting with company staff-up and providing the setup of critical business infrastructure

• Established and drove regular StratEx checks to continually strengthen the launch plan: prompted adjustment in targets 6 weeks after production started, leading to improved patient access / ordering in parallel with CMS coverage decisions

• Specific start-up interim leadership roles, activities and results

​

1. Assumed multiple Management Team roles throughout first 12 months until team was staffed: strategy and execution of early-stage Drug Reimbursement strategy, drafted early and critical Compliance documents, owned all Commercial Analytics and weekly reporting until Analytics Team was funded and hired

2. Created and managed initial Analytics Structures: dosing database, performance analytics, multiple standard and ad-hoc reports (weekly, monthly, ad-hoc; adjusted each month)

3. Provided Customer and Dosing Expertise for business modeling and forecasts; led completion of Working Capital forecast leveraged for future forecasts, production plans and next stage funding

4. Owned all Collaborative Management Relationships with key vendor partners to nurture healthy relationships and mutual value; resolved conflicts, facilitated effective communications, assured inclusive and transparent culture; created bridges to effectively transfer all relationships to permanent owners after management team was hired and prepared for a successful transition

​

• Established and owned G&A to scale and improve operative quality: Operational Strategy & Planning, Budget & Performance Processes, Functional Maturation and Integration (monitored HR/Payroll; setup and monitored Business Compliance, IT and Procurement); created bridges to effectively transfer all functionality to permanent owners after key G&A resources were hired and prepared for a successful transition